{"id":"depofoam-bupivacaine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or reaction"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Systemic toxicity (rare, at high doses)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bupivacaine blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses and thereby producing local anesthesia. The Depofoam delivery system encapsulates bupivacaine in multivesicular liposomes, which gradually release the drug over an extended period (up to 72 hours), allowing for sustained local anesthetic effect without repeated dosing.","oneSentence":"Depofoam bupivacaine is a liposomal formulation of the local anesthetic bupivacaine that provides prolonged anesthesia by slowly releasing bupivacaine from lipid vesicles.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:32:24.666Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infiltration anesthesia and nerve block in surgical procedures"},{"name":"Postoperative analgesia"}]},"trialDetails":[{"nctId":"NCT05171179","phase":"PHASE3","title":"The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2021-10-22","conditions":"Mammaplasty","enrollment":60},{"nctId":"NCT04278846","phase":"PHASE4","title":"Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2014-08-22","conditions":"Pain, Postoperative, Mammaplasty","enrollment":50},{"nctId":"NCT02542956","phase":"PHASE4","title":"Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine for Pain Management","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2014-10","conditions":"Pain","enrollment":""},{"nctId":"NCT04284930","phase":"PHASE4","title":"Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-02","conditions":"Pain, Postoperative","enrollment":21},{"nctId":"NCT03176459","phase":"PHASE4","title":"Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2017-06-01","conditions":"C-Section, Pain Management","enrollment":186}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["liposomal bupivacaine, Exparel"],"phase":"marketed","status":"active","brandName":"Depofoam bupivacaine","genericName":"Depofoam bupivacaine","companyName":"The Cleveland Clinic","companyId":"the-cleveland-clinic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Depofoam bupivacaine is a liposomal formulation of the local anesthetic bupivacaine that provides prolonged anesthesia by slowly releasing bupivacaine from lipid vesicles. Used for Infiltration anesthesia and nerve block in surgical procedures, Postoperative analgesia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}